Implementation Study of Patient-Ready Syringes Containing 25 mg/mL Methotrexate Solution for Use in Treating Ectopic Pregnancy

Background. Ectopic pregnancy (EP) is a significant cause of morbidity and mortality during the first trimester of pregnancy. Small unruptured tubal pregnancies can be treated medically with a single dose of methotrexate (MTX). Objective. The aim of this study was to evaluate the stability of a 25 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Respaud, R., Gaudy, A. S., Arlicot, C., Tournamille, J. F., Viaud-Massuard, M. C., Elfakir, C., Antier, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037123/
https://www.ncbi.nlm.nih.gov/pubmed/24900977
http://dx.doi.org/10.1155/2014/689308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037123/
https://www.ncbi.nlm.nih.gov/pubmed/24900977
http://dx.doi.org/10.1155/2014/689308

Ejemplares similares